Metabolic Aspects of Cell Cycle Regulation in Normal and Cancer Cells

Abstract

Several studies are reviewed dealing with the mechanisms which regulate the cell cycle progression in normal and cancer cells. Using Yoshida AH 130 ascites tumor cells, it has been found that the G₁-S transition of these cells is impaired by specific inhibitors of the electron flow through the respiratory chain (antimycin A), although respiratory ATP can be replaced by glycolytic ATP. The above transition can be also inhibited by the addition of physiologic substrates, mainly pyruvate, by a mechanism which appears linked to a modification of the cellular redox state and can be totally reversed by adding adenine to the culture medium. Adenine equally removes the block produced by antimycin A, pointing out a respiration-linked step of purine metabolism restricting the cell recruitment into S. A substantial protection of this step against the inhibitory effects of pyruvate and antimycin A has been obtained by the addition of folate and tetrahydrofolate, suggesting that the respiration-linked limiting step of tumor cell cycling involves folate metabolism and its connection to purine synthesis. The biologic relevance of these findings is stressed by the fact that pyruvate addition also inhibits the proliferation of concanavalin A-stimulated lymphocytes as well as of bone marrow hemopoietic cells in the presence of colony-stimulating factors. On the other hand, pyruvate only slightly affects the growth kinetics of malignant lymphoblasts and of Friend erythroleukemia cells either in the absence or in the presence of the differentiation inducer dimethylsulfoxide.

References

1. Aisemberg AC (1961). The Glycolysis and Respiration of Tumors. Academic Press, New York, p. 196.

2. Antoniades HN and Owen AJ (1982). Growth factors and regulation of cell growth. Annu. Rev. Med. 33:445–463.

3. Arcangeli A (1984). Unpublished data.

4. Barach AL and Bickermann HA (1954). The effect of anoxia on tumor growth with special reference to sarcoma 180 implanted in C57 mice. Cancer Res. 14: 672–676.

5. Biczowa B , Kieler J , and Moore J (1968). Comparative studies of near-tetraploid and near-diploid line of Ehrlich's ascites tumor propagated in vivo and in vitro. I. Metabolism and growth. Eur. J. Cancer 4: 67–69.

6. Dello Sbara P , Arcangeli A , and Olivotto M (1981). Independence of aerobic glycolysis stimulation from cell recruitment into the cycling state in concanavalin A-treated lymphocytes. Atti XVI Congr. Naz Soc. Ital. Patol. Saint Vincent, 367–368.

7. Dello Sbarba P and Olivotto M (1984). Unpublished data.

8. Del Monte U (1967). Changes in oxygen tension in Yoshida ascites hepatoma during growth. Proc. Soc. Exp. Biol. Med. 125: 853–856.

9. Del Monte U and Olivotto M (1965). Ricerche sulla natura dei substrati della respirazione endogena dell'epatoma ascite di Yoshida. Lo Sperimentale 115: 405–422.

10.

10. Figueras M and Gosalvez M (1973). Inhibition of the growth of Ehrlich ascites tumors by treatment with respiratory inhibitor rotenone. Eur. J. Cancer 9: 529–531.

11.

11. Folkman J (1974). Tumor angiogenesis. Adv. Cancer Res. 19: 331–358.

12.

12. Friedkin M (1963). Enzymatic aspects of folic acid. Annu. Rev. Biochem. 32: 185–214.

13.

13. Gosalvez M , Perez-Garcia J , and Lopez M (1972). Inhibition of NADH-linked respiration with the anti-cancer agent 4-dimethyl epipodophyllotoxin thenylidene glucoside (VM-26). Eur. J. Cancer 8: 471–473.

14.

14. Gregg CT (1972). Some aspects of the energy metabolism of mammalian cells. In: Growth, Nutrition, and Metabolism of Cells in Culture, GH Rothblat and VJ Cristofalo (eds). Academic Press, New York, Vol. 1, pp. 83–136.

15.

15. Gregg CT , Machinist JM , and Currie WD (1968). Glycolytic and respiratory properties of intact mammalian cells. Inhibitor studies. Arch. Biochem. Biophys. 127: 101–111.

16.

16. Harris JW , Meyskens F , and Patt HM (1970). Biochemical studies of cytokinetic changes during tumor growth. Cancer Res. 30: 1937–1944.

17.

17. Hershko A , Mamont P , Schields R , and Tomkins GM (1971). The pleiotypic response. Nature New Biol. 232: 206–211.

18.

18. Olivotto M , Caldini R , Chevanne M , and Cipolleschi MG (1983). The respiration-linked limiting step of tumor cell transition from the noncycling to the cycling state: its inhibition by oxidizable substrates and its relationships to purine metabolism. J. Cell. Physiol. 116: 149–158.

19.

19. Olivotto M and Paloletti F (1974). Protein metabolism in tumor cells at various stages of growth in vivo. J. Cell Biol. 62: 585–593.

20.

20. Olivotto M and Paoletti F (1980). Studies on the kinetics of initial cycle progression in vitro of ascites tumor cells subsequent to isolation from ascites fluid. Cell Tissue Kinet. 13: 605–612.

21.

21. Olivotto M and Paoletti F (1981). The role of respiration in tumor cell transition from the noncycling to the cycling state. J. Cell. Physiol. 107: 243–249.

22.

22. Tannock IF (1968). The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br. J. Cancer 22: 258–273.

23.

23. Tannock IF (1969). A comparison of cell proliferation parameters in solid and ascites Ehrlich tumors. Cancer Res. 29:1527–1534

24.

24. Warburg O (1930). The Metabolism of Tumours. Constable, London.

25.

25. Webster PL and van't Hoff J (1969). Dependence on energy and aerobic metabolism of initiation of DNA synthesis and mitosis by G1 and G2 cells. Exp. Cell Res. 55: 88–94.

26.

26. Wheelock EF , Weinhold KJ , and Levich J (1981). The tumor dormant state. Adv. Cancer Res. 34: 107–140.